中文
About Honglin
Honors
Quality
Culture

About Honglin

We advocate and persue the concept of 
Happy & Healthy Life.

ABOUT US

GoeGoe Honglin Pharm.

Beijing Honglin
Pharma. Co., Ltd.

GoeGoe Honglin Pharmaceutical Co. is an American pharmaceutical company that is technology-driven, innovative and patient-focused, with its headquarters in the USA.
GoeGoe Honglin Pharm. has applied science and our global resources to bring therapies to people that treat diseases and manage chronic conditions. Our USA-based R&D team deeply roots in the field of sustained and controlled release preparation technologies and selects products and equipment through a global lens, strictly adhering to USA technologies, standards, and patents.
Established in China for over 30 years, GoeGoe Honglin Pharm. has become one of the leading foreign-invested pharmaceutical companies in China. Leveraging strong R&D capabilities and global resource advantages, we have launched high-quality products in 7 therapeutic areas in China, including Cardio-cerebrovascular System, Endocrine System, Antipyretic and Analgesic, Digestive system, Anti-cold, Anti-allergy, and Psychiatric System.

Partnerships

◮ University-Enterprise Co-Education
Since 2008, we have launched university-enterprise cooperation with Indiana University (USA) and Shenyang Pharmaceutical University successively, and built internship and practice bases.
◮ Domestic Collaboration
① We have reached trademark licensing and brand strategic cooperation with leading enterprises in the industry, including CR Sanjiu (999), Sunflower Pharm., Fujian Xin Zi Jin Curative, and Guoda Drugstore.
② China Resources Pharmaceutical Commercial Group has visited our company for many times to explore opportunities for strategic cooperation in China's pharmaceutical industry.
◮ International Partnership
① In 2014, our product "HOWELT®" passed a comprehensive evaluation and signed a strategic cooperation contract with Xi'an Janssen (now Johnson & Johnson Innovative Medicine).
② In 2024, we conducted cooperation with Kato, a raw material supplier from Belarus, to assist Kato in expanding the international market.

Partnerships

Strength

  • 01

    Technology Origin

    Our core technology is inherited from ALZA, the originator of osmotic pump controlled-release technology. We have invited the patent inventor of this controlled-release technology to provide technical support, realizing the accurate implementation and systematic inheritance of this core technology. Notably, ALZA has presented the world's first fully automatic mechanical drilling machine uesd for controlled-release tablet testing to our company for commemoration.

  • 02

    Imported Equipment

    For GoeGoe Honglin Pharm., all core equipment and key raw materials & auxiliary materials are imported from abroad. Through this, we achieve dual leadership in batch volume and quality, further reduces material losses and production costs significantly, and ultimately attains a dual balance between efficient production and high quality.

  • 03

    Chinese Patents

    After multiple generations of technological upgrades, we have established a controlled-release technology platform with independent R&D patents, and have successfully developed controlled-release products that achieve zero-order rate release of drugs. Our core technology has obtained 5 Chinese patents and maintains a leading position in the industry.

  • Technology Origin

    Our core technology is inherited from ALZA, the originator of osmotic pump controlled-release technology. We have invited the patent inventor of this controlled-release technology to provide technical support, realizing the accurate implementation and systematic inheritance of this core technology. Notably, ALZA has presented the world's first fully automatic mechanical drilling machine uesd for controlled-release tablet testing to our company for commemoration.

    Imported Equipment

    For GoeGoe Honglin Pharm., all core equipment and key raw materials & auxiliary materials are imported from abroad. Through this, we achieve dual leadership in batch volume and quality, further reduces material losses and production costs significantly, and ultimately attains a dual balance between efficient production and high quality.

    Chinese Patents

    After multiple generations of technological upgrades, we have established a controlled-release technology platform with independent R&D patents, and have successfully developed controlled-release products that achieve zero-order rate release of drugs. Our core technology has obtained 5 Chinese patents and maintains a leading position in the industry.

    Fulfilling Lives, with Health and Happiness!

    Our Corporate Philosophy

    2021 官网升级中!现在您访问官网的浏览器设备分辨率宽度低于1280px
    请使用高分辨率宽度访问。